Skip to content

Insider · CIK 0001980144

Anil P. Ranganath

officer

Files at TMDX (TransMedics Group, Inc.). First filing Jun 10, 2025, latest Mar 4, 2026.

In brief

Anil P. Ranganath files SEC Form 4 as officer at TMDX (TransMedics Group, Inc.). Since Jun 10, 2025, Anil P. Ranganath has reported 0 open-market buys worth $0 and 3 open-market sells worth $652k, the latest filed on Mar 4, 2026.

A track record needs three past buys with six months of prices behind them; Anil P. Ranganath has 0, so none is measured yet.

The newest scored trade: sold $120k of TMDX on Mar 2, 2026, filed Mar 4, 2026, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $556k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $652k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TMDX: TransMedics Group, Inc.

TMDXOct 9, 2026 · close 77.87

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
TMDXsell 5
TransMedics Group, Inc.
$120k
864 shares
-6%+128% from low-2% from high
37Weak
TMDXsell 3
TransMedics Group, Inc.
$436k
3,000 shares
-18%+157% from low0% from high
33Weak
TMDXsell 2
TransMedics Group, Inc.
$96k
686 shares
-5%+146% from low-16% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Nov 25, 2025 TMDX
TRANSMEDICS GROUP, INC.
3,000
0.01% of outstanding
$436kNov 25, 2025none

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 2, 2026TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock
-864$139.12$120k13,091Mar 4, 2026
Nov 25, 2025TMDX
TransMedics Group, Inc.
MOption exercise
Common Stock
+3,000$93.88$282k16,955Nov 26, 2025
Nov 25, 2025TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock
-3,000$145.22$436k13,955Nov 26, 2025
Nov 25, 2025TMDX
TransMedics Group, Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-3,000$0.00$07,420Nov 26, 2025
Jun 9, 2025TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock
-686$139.80$96k13,955Jun 10, 2025

Questions about Anil P. Ranganath

Answered from the filings on this page, as of the latest one.

Is Anil P. Ranganath buying or selling?

In the last 12 months Anil P. Ranganath reported 0 open-market buys worth $0 and 2 open-market sells worth $556k on SEC Form 4; the latest was sold $120k of TMDX on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.

How did Anil P. Ranganath's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anil P. Ranganath has 0.

Where does Anil P. Ranganath file Form 4?

Anil P. Ranganath has filed Form 4 at TMDX (TransMedics Group, Inc.) as See remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Anil P. Ranganath: insider trades and track record | InsiderTell